Cancer BiologybioRxiv
Association of tamoxifen resistance and lipid reprogramming in breast cancer.
S. Hultsch, M. Kankainen, L. Paavolainen…·O. Kallioniemi
This study identifies lipid reprogramming and lysosomal membrane permeabilization (LMP) prevention as key mechanisms of tamoxifen resistance in breast cancer, suggesting new therapeutic targets.
DOI 10.1186/s12885-018-4757-z